
By Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed
Advertisement
Articles by By Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Ketamine for Treatment-Resistant Depression: Practical Clinical Considerations
2
sNDA Submitted: Caplyta for the Treatment of Bipolar Mania
3
Real-World Lecanemab Outcomes in Alzheimer Disease, Reported at 3 Years
4
Mixed Results From Phase 3 Data for AR1001 in Alzheimer Disease
5

